Literature DB >> 25460147

A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.

David J Brayden, John Gleeson, Edwin G Walsh.   

Abstract

There is debate over the narrow safety margin of many oral permeation enhancers. The sodium salts of medium chain fatty acids (MCFAs) are components of selected oral peptide formulations being assessed in advanced clinical studies. The aim of the study was to examine the effects of the C8-C12 series on filter-grown Caco-2 monolayers and cells grown on 96 well plates in order to dissect the relationship between paracellular permeability enhancement (Papp of [14C]mannitol, reduction in TEER), critical micellar concentration (CMC), and sub-lethal cytotoxicity (high content analysis (HCA). There was a high degree of correlation between the EC50 for increasing the Papp with reduction in transepithelial electrical resistance (TEER), and with CMC values. C8 had the highest EC50 and highest CMC value and was the least cytotoxic, while C12 had the reverse, suggesting a close association between increases in chain length with increases in permeability, hydrophobicity and cytotoxicity. HCA revealed further association between MCFA-induced intracellular calcium increases and plasma membrane permeability reductions in Caco-2 cells with the EC50 to increase the Papp across monolayers. HCA identified sub-lethal cytotoxicity in a series of MCFA and related cell parameters to physicochemical properties and efficacy as intestinal permeation enhancers. These mild surfactants therefore non-specifically partition into the plasma membrane causing membrane fluidization, which is associated with concentration-dependent increases in permeability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25460147     DOI: 10.1016/j.ejpb.2014.10.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  13 in total

Review 1.  Safety concerns over the use of intestinal permeation enhancers: A mini-review.

Authors:  Fiona McCartney; John P Gleeson; David J Brayden
Journal:  Tissue Barriers       Date:  2016-04-12

2.  Biomaterial-tight junction interaction and potential impacts.

Authors:  Xiangfei Han; Ershuai Zhang; Yuanjie Shi; Boyi Song; Hong Du; Zhiqiang Cao
Journal:  J Mater Chem B       Date:  2019-07-31       Impact factor: 6.331

3.  Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.

Authors:  V Stuettgen; D J Brayden
Journal:  AAPS J       Date:  2020-01-27       Impact factor: 4.009

4.  Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.

Authors:  Sam Maher; Mekki Medani; Nestor N Carballeira; Desmond C Winter; Alan W Baird; David J Brayden
Journal:  AAPS J       Date:  2016-10-13       Impact factor: 4.009

5.  Introduction for the special issue on recent advances in drug delivery across tissue barriers.

Authors:  Randall J Mrsny; David J Brayden
Journal:  Tissue Barriers       Date:  2016-06-07

6.  Effects of medium-chain fatty acids on the structure and immune response of IPEC-J2 cells.

Authors:  B Martínez-Vallespín; W Vahjen; J Zentek
Journal:  Cytotechnology       Date:  2016-08-23       Impact factor: 2.058

7.  Aggregation Behavior of Medium Chain Fatty Acids Studied by Coarse-Grained Molecular Dynamics Simulation.

Authors:  Md Shakhawath Hossain; Staffan Berg; Christel A S Bergström; Per Larsson
Journal:  AAPS PharmSciTech       Date:  2019-01-09       Impact factor: 3.246

8.  Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies.

Authors:  Fiona McCartney; Mónica Rosa; David J Brayden
Journal:  Pharmaceutics       Date:  2019-10-31       Impact factor: 6.321

9.  A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin.

Authors:  Irene Santalices; Carlos Vázquez-Vázquez; Manuel J Santander-Ortega; Victoria Lozano; Francisca Araújo; Bruno Sarmento; Neha Shrestha; Veronique Préat; Miguel Chenlo; Clara V Alvarez; Federico Benetti; Juan Cuñarro; Sulay Tovar; Dolores Torres; María José Alonso
Journal:  Drug Deliv Transl Res       Date:  2021-02-11       Impact factor: 4.617

10.  Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.

Authors:  Shakhawath Hossain; Paul Joyce; Albin Parrow; Silver Jõemetsa; Fredrik Höök; Per Larsson; Christel A S Bergström
Journal:  Mol Pharm       Date:  2020-10-08       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.